Peer Review History
| Original SubmissionNovember 13, 2024 |
|---|
|
Dear Dr. Liang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. There are minor revisions suggested by the reviewers. Please submit your revised manuscript by Feb 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ejaz Ahmad Khan, M.D, MPH, FFPH Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 4. We note that Figure 2 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Thank you for analyzing the global, national and regional trends of cataract. Few of my comments are: Please write full form of the words in abstract and before the start of sections. Please align with PLOS one guideline, as the line number are missing in manuscript. Reviewer #2: REVIEW OF MANUSCRIPT: PONE-D-24-51666 1. Overall, the manuscript appears to be well-structured, thorough, and provides valuable insights into the “Global, regional, and national burden of cataract and projections from 1990 to 2021.Data provided by the researchers is adequate, however, it would be of more benefit if the discussion section provided a more comprehensive analysis of the implications of the research findings. 2. Abstract The abstract provides a concise overview of the research conducted in this manuscript. However, the objective and the title seem not to agree . The result says that there is a global decline while conclusion says there is a global increase. The author needs to pay attention to the abstract to make it more coherent. 3. Introduction: The introduction effectively tried to discuss the global trends on cataract and management of cataract. a. Line 41-43: Statement is not entirely correct. Where is the place for age-related cataract as a major cause of visual impairment and blindness? b. Line 45-46: True statement but what would be the reason for this? Readers need to know. c. Line 46-49: Please include reference. d. Line 60: Kindly clarify what you mean by scope and what the limitations were. 4. Methods: The materials and methods section are comprehensive and well-structured however the information needs to be presented in a step wise manner for more clarity. a. Line 85: Kindly change sex to gender. b. Line 98-99: Check the acronym represented. c. Line 106: Write SDI in full d. Line 108-111: Include a reference e. Line 126-128: Include a reference f. Line 142-143: Rephrase “The increase in DALYs was primarily attributable to females”. 5. Result: The results section is detailed having various subheadings that looked at several subheadings relevant to the paper. a. Kindly number the tables/figures appropriately as figures and appendix are used interchangeably. Also, it is important not to include all the information on the studies included in the paper. Key /relevant finding should be included as prose, and this would significantly reduce the word count of the paper. b. Line 227: Kindly rephrase c. Line 229: “procedural pathways” Management of cataract starts from history taking to post op care. I would assume that procedural management means clinical guidelines. This doesn’t come out clear so you may ant to rephrase the line. 6. Discussion: The discussion section of the manuscript provides a detailed overview of the study's findings regarding the prevalence and DALY as well as global trends in the burden of cataract. However, there are some aspects that could benefit from clarification, refinement, or expansion: a. Line 229-230: Is this a global representation? d. Line 231: Kindly expand on what situation is. e. Line 234-235: This is a known fact and should be in your background. f. Line 235-236: Kindly add reference. g. Line 238-230: “Cataract-induced” Rather use cataract- related visual impairment and blindness or visual impairment and blindness from cataract particularly in the elderly” h. Line 245: replace SEXES with GENDER i. Line 250: replace Imbalance with “Gender inequality” j. Line 266: What kind of dietary habits? k. Line 278 & line 283: use a more scientific paper appropriate phrase to start the sentence. l. Line 300: Environmental factors m. Line 317:” Effective cataract surgical coverage” You should introduce this concept in the background and then analyse in results before the discussion. n. Line 341-342: There is a new strategy called “2030 right to sight”. Vision 2020 is relevant however it is better to cite more recent publication “World Report on Vision” . o. Line 346-347: RAAB is a survey, and it is related to Effective cataract surgical coverage p. Line 350-351: Promoting prenatal diagnostics and screening for high-risk genes associated with cataract formation can help detect congenital cataracts however higher prevalence of cataracts are age related cataract. 7. References: References are relevant to the topic and are recent papers, Check the following references and ensure uniformity of referencing style that is journal appropriate. 5, 8, 15, 33. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Dilichukwu Isioma Aniemeka ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Global, regional, and national burden of cataract: A comprehensive analysis and projections from 1990 to 2021 PONE-D-24-51666R1 Dear Dr. Liang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Osamudiamen Cyril Obasuyi, MD, MSc, FWACS, FMCOPh Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-24-51666R1 PLOS ONE Dear Dr. Liang, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Osamudiamen Cyril Obasuyi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .